Medicine Man Technologies, Inc. Share Price Other OTC
Equities
SHWZ
US58468U1060
Pharmaceuticals
Sales 2024 * | 174M 14.54B | Sales 2025 * | 192M 16.06B | Capitalization | 48.51M 4.05B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 0.28 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.25 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 78.06% |
Latest transcript on Medicine Man Technologies, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 16/23/16 | |
Justin Dye
CHM | Chairman | 52 | 05/19/05 |
Ed Eissenstat
CTO | Chief Tech/Sci/R&D Officer | - | 01/22/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kathy Vrabeck
BRD | Director/Board Member | 60 | 02/11 |
Jeffrey Cozad
BRD | Director/Board Member | 60 | 15/21/15 |
Marc Rubin
BRD | Director/Board Member | 50 | 28/22/28 |
1st Jan change | Capi. | |
---|---|---|
+39.33% | 6.11B | |
-18.38% | 4.35B | |
-9.17% | 3.18B | |
+3.98% | 3.15B | |
-3.41% | 2.51B | |
+48.74% | 1.98B | |
-4.82% | 1.74B | |
-1.24% | 1.63B | |
-8.96% | 1.6B |